José‐Francisco Rocha

Pharmacokinetic and safety profile of<i>trans</i>‐resveratrol in a rising multiple‐dose study in healthy volunteers

Luís Almeida, Manuel Vaz‐da‐Silva, Amílcar Falcão et al. · Molecular Nutrition & Food Research · 2009 · 421 citations

Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

Joaquim J. Ferreira, Andrew J. Lees, José‐Francisco Rocha et al. · The Lancet Neurology · 2015 · 273 citations

Parkinson Disease, Neuropharmacology, Motor Control +6

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations

Andrew J. Lees, Joaquim J. Ferreira, Olivier Rascol et al. · JAMA Neurology · 2016 · 176 citations

Pharmacokinetics of <i>Trans</i>‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects

Teresa Nunes, Luís Almeida, José‐Francisco Rocha et al. · The Journal of Clinical Pharmacology · 2009 · 108 citations

Aging, Geriatrics, Young Subjects +6

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

José‐Francisco Rocha, Amílcar Falcão, A. Santos et al. · European Journal of Clinical Pharmacology · 2014 · 65 citations

Levodopa Pharmacokinetics, Pharmacology, Neuropharmacology +3